FDA Clears Human Hookworm Vaccine for Phase I Safety Trials
Submitted by Sabin on
Sabin/GW Researchers Receive Word on Investigational New Drug Status for Vaccine
© 2022 • Sabin Vaccine Institute • 2175 K Street, NW, Suite 400 • Washington, DC 20037 • +1 202 842 5025